This study aimed to examine RhoA, a mutation-susceptible locus-derived protein, and vigilin (high-density lipoprotein-binding protein; HDLBP), an endoplasmic reticulum (ER)-localised protein, as potential diagnostic markers of epithelioid MM. The gene discussed is HDLBP; the disease is Miyoshi myopathy.